A rational approach to migraine diagnosis and management in primary care

References

• Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2018;17(11):954–976.
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Stovner LJ, Vos T, et al. Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain. 2018;19(1):17.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–349.
   PubMed Web of Science ®Google Scholar
• Marmura MJ. Triggers, protectors, and predictors in episodic migraine. Curr Pain Headache Rep. 2018;22(12):81.
   PubMed Web of Science ®Google Scholar
• Andress-Rothrock D, King W, Rothrock J. An analysis of migraine triggers in a clinic-based population. Headache. 2010;50(8):1366–1370.
   PubMed Web of Science ®Google Scholar
• Pilati L, Battaglia G, Di Stefano V, et al. Migraine and sport in a physically active population of students: results of a cross-sectional study. Headache. 2020;60(10):2330–2339.
   PubMed Web of Science ®Google Scholar
• Di Stefano V, Ornello R, Gagliardo A, et al. Social distancing in chronic migraine during the COVID-19 outbreak: results from a multicenter observational study. Nutrients. 2021;13(4):1361.
   PubMed Web of Science ®Google Scholar
• Finley CR, Chan DS, Garrison S, et al. What are the most common conditions in primary care? Systematic review. Can Fam Physician. 2018;64(11):832–840.
   PubMed Web of Science ®Google Scholar
• Peabody MR, O'Neill TR, Stelter KL, et al. Frequency and criticality of diagnoses in family medicine practices: from the national ambulatory medical care survey (NAMCS). J Am Board Fam Med. 2018;31(1):126–138.
   PubMed Web of Science ®Google Scholar
• Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia. 2018;38(1):1–211.
   PubMed Web of Science ®Google Scholar
• Tepper SJ, Dahlof CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the landmark study. Headache. 2004;44(9):856–864.
   PubMed Web of Science ®Google Scholar
• Martin VT TR, Al-Shaikh E, Martin AT, Levin LS, editors. Comorbid medical disorders and migraine: does gender make a difference? International headache congress. Boston (MA): Cephalalgia; 2013.
   Google Scholar
• Becker WJ, Findlay T, Moga C, et al. Guideline for primary care management of headache in adults. Can Fam Physician. 2015;61(8):670–679.
   PubMed Web of Science ®Google Scholar
• Dodick DW, Loder EW, Manack Adams A, et al. Assessing barriers to chronic migraine consultation, diagnosis, and treatment: Results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache. 2016;56(5):821–834.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Serrano D, Holland S, et al. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features. Headache. 2013;53(1):81–92.
   PubMed Web of Science ®Google Scholar
• Viana M, Sances G, Ghiotto N, et al. Variability of the characteristics of a migraine attack within patients. Cephalalgia. 2016;36(9):825–830.
   PubMed Web of Science ®Google Scholar
• Vollesen AL, Benemei S, Cortese F, et al. Migraine and cluster headache – the common link. J Headache Pain. 2018;19(1):89.
   PubMed Web of Science ®Google Scholar
• Evans RW, Seifert T, Kailasam J, et al. The use of questions to determine the presence of photophobia and phonophobia during migraine. Headache. 2008;48(3):395–397.
   PubMed Web of Science ®Google Scholar
• Yoon MS, Katsarava Z, Obermann M, et al. Prevalence of primary headaches in Germany: results of the German Headache Consortium study. J Headache Pain. 2012;13(3):215–223.
   PubMed Web of Science ®Google Scholar
• Stang PE, Von Korff M. The diagnosis of headache in primary care: factors in the agreement of clinical and standardized diagnoses. Headache. 1994;34(3):138–142.
   PubMed Web of Science ®Google Scholar
• Tsiga E, Panagopoulou E, Sevdalis N, et al. The influence of time pressure on adherence to guidelines in primary care: an experimental study. BMJ Open. 2013;3(4):e002700.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Hahn SR, Cady RK, et al. In-office discussions of migraine: results from the American Migraine Communication study. J Gen Intern Med. 2008;23(8):1145–1151.
   PubMed Web of Science ®Google Scholar
• Evans RW. The clinical features of migraine with and without aura. Practical Neurology. 2014;14:26–32.
   Google Scholar
• Lai TH, Fuh JL, Wang SJ. Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache. J Neurol Neurosurg Psychiatry. 2009;80(10):1116–1119.
   PubMed Web of Science ®Google Scholar
• Kelman L. Migraine pain location: a tertiary care study of 1283 migraineurs. Headache. 2005;45(8):1038–1047.
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache. 1995;35(7):387–396.
   PubMed Web of Science ®Google Scholar
• Martins IP, Gouveia RG, Parreira E. Kinesiophobia in migraine. J Pain. 2006;7(6):445–451.
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Jensen R, Katsarava Z, et al. Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting the Burden: the Global Campaign against Headache. J Headache Pain. 2019;20(1):57.
   PubMed Web of Science ®Google Scholar
• Dodick DW. Pearls: headache. Semin Neurol. 2010;30(1):74–81.
   PubMed Web of Science ®Google Scholar
• Chiang C-C, VanderPluym J. Diagnosing secondary headaches. Practical Neurology. 2020;20.
   Google Scholar
• Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: the ID migraine validation study. Neurology. 2003;61(3):375–382.
   PubMed Web of Science ®Google Scholar
• Robbins MS. Diagnosis and management of headache: a review. JAMA. 2021;325(18):1874–1885.
   PubMed Web of Science ®Google Scholar
• Beithon J, Gallenberg M, Johnson K, et al. Diagnosis and Treatment of Headache: Healthcare Guideline Bloomington, MN: Institute for Clinical Systems Improvement; 2013. [11th]. Available from: https://www.icsi.org/wp-content/uploads/2019/01/Headache.pdf
   Google Scholar
• Brennan KC, Charles A. An update on the blood vessel in migraine. Curr Opin Neurol. 2010;23(3):266–274.
   PubMed Web of Science ®Google Scholar
• Ahn AH. Southern headache society supplement: the neurobiology of throbbing pain in migraine. Headache. 2012;52(Suppl 1):12–14.
   PubMed Web of Science ®Google Scholar
• Edvinsson L, Haanes KA, Warfvinge K, et al. CGRP as the target of new migraine therapies – successful translation from bench to clinic. Nat Rev Neurol. 2018;14(6):338–350.
   PubMed Web of Science ®Google Scholar
• Ashina M. Migraine. N Engl J Med. 2020;383(19):1866–1876.
   PubMed Web of Science ®Google Scholar
• Barbanti P, Brighina F, Egeo G, et al. Migraine as a cortical brain disorder. Headache. 2020;60(9):2103–2114.
   PubMed Web of Science ®Google Scholar
• Di Stefano V, Rispoli MG, Pellegrino N, et al. Diagnostic and therapeutic aspects of hemiplegic migraine. J Neurol Neurosurg Psychiatry. 2020;91(7):764–771.
   PubMed Web of Science ®Google Scholar
• Sheerin UM, Stamelou M, Charlesworth G, et al. Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation. J Neurol. 2013;260(2):656–660.
   PubMed Web of Science ®Google Scholar
• de Boer I, van den Maagdenberg A, Terwindt GM. Advance in genetics of migraine. Curr Opin Neurol. 2019;32(3):413–421.
   PubMed Web of Science ®Google Scholar
• Ailani J, Burch RC, Robbins MS. The American Headache Society Consensus statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021–1039.
   PubMed Web of Science ®Google Scholar
• Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society Evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3–20.
   PubMed Web of Science ®Google Scholar
• Croop R, Goadsby PJ, Stock DA, et al. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet. 2019;394(10200):737–745.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Dodick DW, Ailani J, et al. Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial. JAMA. 2019;322(19):1887–1898.
   PubMed Web of Science ®Google Scholar
• May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455–464.
   PubMed Web of Science ®Google Scholar
• Burch R. Antidepressants for preventive treatment of migraine. Curr Treat Options Neurol. 2019;21(4):18.
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53(4):644–655.
   PubMed Web of Science ®Google Scholar
• Charles A, Pozo-Rosich P. Targeting calcitonin gene-related peptide: a new era in migraine therapy. Lancet. 2019;394(10210):1765–1774.
   PubMed Web of Science ®Google Scholar
• Ashina M, Goadsby PJ, Reuter U, et al. Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial. Eur J Neurol. 2021;28(5):1716–1725.
   PubMed Web of Science ®Google Scholar
• Aimovig (erenumab-aooe) [package insert]. Thousand Oaks, CA: Amgen Inc. 2021.
   Google Scholar
• Goadsby PJ, Dodick DW, Ailani J, et al. Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trial. Lancet Neurol. 2020;19(9):727–737.
   PubMed Web of Science ®Google Scholar
• Croop R, Lipton RB, Kudrow D, et al. Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial. Lancet. 2021;397(10268):51–60.
   PubMed Web of Science ®Google Scholar
• Nurtect ODT (rimegepant) [package insert]. New Haven (CT): Biohaven Pharmaceuticals Inc.; 2021.
   Google Scholar
• Gazerani P. Migraine and diet. Nutrients. 2020;12(6):1658.
   PubMed Web of Science ®Google Scholar